Pharma Bulletin

FDA Approves Darolutamide (NUBEQA®) For Metastatic Castration-Sensitive Prostate Cancer

FDA approves Darolutamide for metastatic castration-sensitive prostate cancer FDA approves darolutamide for metastatic castration-sensitive prostate cancer on june 3, 2025. […]

Pharmacovigilance via VigiMobile app- Smart Reporting.

VigiMobile app, a smart way to report ADR| Core of medical profession- essential to be known by every healthcare professional| Also get to known how to download the App.

Pharma Bulletin

Recall Alert-Homegrown Family Foods Issues Allergy Alert on Undeclared Milk in Shore Lunch Oven Style Breader & Batter Mix

Recall Alert-Homegrown Family Foods Issues Allergy Alert on Undeclared Milk in Shore Lunch Oven Style Breader & Batter Mix Homegrown